Arrowhead Pharmaceuticals Stock Price on October 23, 2024
| ARWR Stock | USD 26.42 0.27 1.03% |
Below is the normalized historical share price chart for Arrowhead Pharmaceuticals extending back to December 16, 1993. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arrowhead Pharmaceuticals stands at 26.42, as last reported on the 29th of November, with the highest price reaching 26.62 and the lowest price hitting 22.25 during the day.
If you're considering investing in Arrowhead Stock, it is important to understand the factors that can impact its price. Arrowhead Pharmaceuticals appears to be somewhat reliable, given 3 months investment horizon. Arrowhead Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0703, which signifies that the company had a 0.0703% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Arrowhead Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please makes use of Arrowhead Pharmaceuticals' Mean Deviation of 2.71, risk adjusted performance of 0.0471, and Downside Deviation of 3.33 to double-check if our risk estimates are consistent with your expectations.
At this time, Arrowhead Pharmaceuticals' Common Stock Total Equity is relatively stable compared to the past year. As of 11/29/2024, Common Stock Shares Outstanding is likely to grow to about 125.8 M, while Common Stock is likely to drop slightly above 206.2 K. . At this time, Arrowhead Pharmaceuticals' Price To Sales Ratio is relatively stable compared to the past year. As of 11/29/2024, Price Book Value Ratio is likely to grow to 13.14, though Price Earnings To Growth Ratio is likely to grow to (0.02). Arrowhead Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of June 1993 | 200 Day MA 24.4316 | 50 Day MA 19.9522 | Beta 0.934 |
Arrowhead |
Sharpe Ratio = 0.0703
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ARWR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.53 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.32 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Arrowhead Pharmaceuticals is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arrowhead Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 17.5469 | Enterprise Value Ebitda (11.02) | Price Sales 165.6122 | Shares Float 110.5 M | Wall Street Target Price 45.3846 |
Related Headline
CytomX Therapeutics Headline on 23rd of October 2024
Alphina Therapeutics Appoints Veteran Biotech Executive, Nic... by finance.yahoo.com
Alphina Therapeutics, a biotechnology company developing a best-in-class NAMPT inhibitor for the treatment of a range of solid tumor indications, today announced that it has appointed Nick Galli as chief executive officer and a member of the board of directors. Mr. Galli brings nearly twenty years of private and public pharmaceutical and biotechnology industry experience with a focus on strategy, company building, and business development. As an executive, he has helped biotech companies raise o
Arrowhead Pharmaceuticals Valuation on October 23, 2024
It is possible to determine the worth of Arrowhead Pharmaceuticals on a given historical date. On October 23, 2024 Arrowhead was worth 20.26 at the beginning of the trading date compared to the closed value of 19.92. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arrowhead Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Arrowhead Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arrowhead Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arrowhead Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 20.46 | 20.50 | 20.02 | 20.38 | 560,550 | |
10/23/2024 | 20.26 | 20.43 | 19.68 | 19.92 | 615,099 |
| 20.02 | 20.36 | 19.71 | 19.93 | 651,178 |
| Backtest Arrowhead Pharmaceuticals | | | Arrowhead Pharmaceuticals History | | | Arrowhead Pharmaceuticals Valuation | Previous | Next |
Arrowhead Pharmaceuticals Trading Date Momentum on October 23, 2024
| On October 24 2024 Arrowhead Pharmaceuticals was traded for 19.93 at the closing time. The top price for the day was 20.36 and the lowest listed price was 19.71 . The trading volume for the day was 651.2 K. The trading history from October 24, 2024 was a factor to the next trading day price gain. The overall trading delta against the next closing price was 0.05% . The overall trading delta against the current closing price is 1.91% . |
Arrowhead Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Arrowhead Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arrowhead Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arrowhead financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Arrowhead Pharmaceuticals Stock history
Arrowhead Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arrowhead is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arrowhead Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arrowhead Pharmaceuticals stock prices may prove useful in developing a viable investing in Arrowhead Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 119.8 M | 125.8 M | |
| Net Loss | -184.7 M | -175.5 M |
Arrowhead Pharmaceuticals Quarterly Net Working Capital |
|
Arrowhead Pharmaceuticals Stock Technical Analysis
Arrowhead Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Arrowhead Pharmaceuticals Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Arrowhead Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Arrowhead Pharmaceuticals November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Arrowhead Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arrowhead Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Arrowhead Pharmaceuticals stock market strength indicators, traders can identify Arrowhead Pharmaceuticals entry and exit signals to maximize returns
Arrowhead Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arrowhead Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Arrowhead Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arrowhead to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0471 | |||
| Jensen Alpha | 0.0492 | |||
| Total Risk Alpha | (0.46) | |||
| Sortino Ratio | 0.0307 | |||
| Treynor Ratio | 0.149 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.